{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:45:40Z","timestamp":1792669540919,"version":"4.5.0"},"reference-count":30,"publisher":"PAGEPress Publications","issue":"4","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Histochem"],"abstract":"<jats:p>Bladder cancer (BCa) is a common malignancy of the urinary system, and its malignant progression is closely associated with ferroptosis. As a transcriptional regulator in the AFF family, AFF3 participates in the regulation of gene expression in multiple diseases; however, its role in BCa and its relationship with ferroptosis remain unclear. This study aimed to investigate the role of AFF3 in BCa progression and the molecular mechanism through which it regulates ferroptosis. AFF3 expression was examined through bioinformatics analysis and experiments in clinical tissues and cells. AFF3 was overexpressed in UM-UC-3 cells, and cell proliferation and migration were assessed using CCK-8, colony formation, and Transwell assays. Ferroptosis was evaluated using BODIPY 581\/591 C11, MDA, and ferroptosis-related protein assays, and rescue experiments were performed with the ferroptosis inhibitor Fer-1. A subcutaneous xenograft model was established in nude mice, and the NRF2 activator TBHQ was used to verify the in vivo role and mechanism of AFF3 in regulating ferroptosis. Our results revealed that AFF3 was expressed at low levels in BCa. Functionally, AFF3 overexpression inhibited BCa cell proliferation, colony formation, and migration; promoted the accumulation of lipid ROS and MDA; downregulated GPX4 and SLC7A11 expression; and increased sensitivity to ferroptosis. Notably, Fer-1 partially reversed these effects. Mechanistically, AFF3 upregulated KEAP1 and inhibited NRF2 nuclear translocation, thereby reducing GPX4 expression; conversely, TBHQ partially reversed these molecular and functional changes. In vivo animal experiments further confirmed that AFF3 overexpression inhibited xenograft growth and promoted ferroptosis-related changes, whereas TBHQ attenuated the regulatory effects of AFF3. Overall, these findings demonstrate that AFF3 exerts tumor-suppressive effects in BCa by promoting KEAP1 expression and inhibiting NRF2 nuclear translocation and GPX4-mediated antioxidant defense, thereby enhancing the sensitivity of tumor cells to ferroptosis and suppressing the malignant progression of BCa.<\/jats:p>","DOI":"10.4081\/ejh.2026.4756","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:36:18Z","timestamp":1792668978000},"source":"Crossref","is-referenced-by-count":0,"title":["AFF3 regulates ferroptosis and malignant progression in bladder cancer cells &lt;i&gt;via&lt;\/i&gt; the NRF2\/GPX4 signaling axis"],"prefix":"10.4081","volume":"70","author":[{"given":"Song","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2549","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"54438","doi-asserted-by":"crossref","unstructured":"1. Filho AM, Briganti A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2026;89:426-36.","DOI":"10.1016\/j.eururo.2025.12.011"},{"key":"54439","doi-asserted-by":"crossref","unstructured":"2. Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ 2024;384:e076743.","DOI":"10.1136\/bmj-2023-076743"},{"key":"54440","doi-asserted-by":"crossref","unstructured":"3. Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol 2024;25:424-42.","DOI":"10.1038\/s41580-024-00703-5"},{"key":"54441","doi-asserted-by":"crossref","unstructured":"4. An WX, Gupta R, Zhai K, Wang YR, Xu WH, Cui Y. Current and potential roles of ferroptosis in bladder cancer. Curr Med Sci 2024;44:51-63.","DOI":"10.1007\/s11596-023-2814-6"},{"key":"54442","doi-asserted-by":"crossref","unstructured":"5. Luo Z, Lin C, Guest E, Garrett AS, Mohaghegh N, Swanson S, et al. The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output. Mol Cell Biol 2012;32:2608-17.","DOI":"10.1128\/MCB.00182-12"},{"key":"54443","doi-asserted-by":"crossref","unstructured":"6. von Bergh ARM, Beverloo HB, Rombout P, van Wering ER, van Weel MH, Beverstock GC, et al. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. Gene Chromosome Canc 2002;35:92-6.","DOI":"10.1002\/gcc.10091"},{"key":"54444","doi-asserted-by":"crossref","unstructured":"7. Shi Y, Zhao Y, Zhang Y, AiErken N, Shao N, Ye R, et al. AFF3 upregulation mediates tamoxifen resistance in breast cancers. J Exp Clin Canc Res 2018;37:254.","DOI":"10.1186\/s13046-018-0928-7"},{"key":"54445","doi-asserted-by":"crossref","unstructured":"8. Fan A, Li Y, Zhang Y, Meng W, Pan W, Chen M, et al. Loss of AR-regulated AFF3 contributes to prostate cancer progression and reduces ferroptosis sensitivity by downregulating ACSL4 based on single-cell sequencing analysis. Apoptosis 2024;29:1679-95.","DOI":"10.1007\/s10495-024-01941-w"},{"key":"54446","doi-asserted-by":"crossref","unstructured":"9. Bellezza I, Giambanco I, Minelli A, Donato R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res 2018;1865:721-33.","DOI":"10.1016\/j.bbamcr.2018.02.010"},{"key":"54447","doi-asserted-by":"crossref","unstructured":"10. Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov 2019;18:295-317.","DOI":"10.1038\/s41573-018-0008-x"},{"key":"54448","doi-asserted-by":"crossref","unstructured":"11. Fan L, Guo D, Zhu C, Gao C, Wang Y, Yin F, et al. LRRC45 accelerates bladder cancer development and ferroptosis inhibition via stabilizing NRF2 by competitively KEAP1 interaction. Free Radic Biol Med 2025;226:29-42.","DOI":"10.1016\/j.freeradbiomed.2024.11.001"},{"key":"54449","doi-asserted-by":"crossref","unstructured":"12. Kang X, Huo Y, Jia S, He F, Li H, Zhou Q, et al. Silenced LINC01134 enhances oxaliplatin sensitivity by facilitating ferroptosis through GPX4 in hepatocarcinoma. Front Oncol 2022;12:939605.","DOI":"10.3389\/fonc.2022.939605"},{"key":"54450","doi-asserted-by":"crossref","unstructured":"13. Zhu H, Chen Q, Zhang Y, Zhao L. Glutathione S-transferase zeta 1 alters the HMGB1\/GPX4 axis to drive ferroptosis in bladder cancer cells. Hum Exp Toxicol 2023;42:9603271231161606.","DOI":"10.1177\/09603271231161606"},{"key":"54451","doi-asserted-by":"crossref","unstructured":"14. Xiang Y, Chen X, Wang W, Zhai L, Sun X, Feng J, et al. Natural product erianin inhibits bladder cancer cell growth by inducing ferroptosis via NRF2 inactivation. Front Pharmacol 2021;12:775506.","DOI":"10.3389\/fphar.2021.775506"},{"key":"54452","unstructured":"15. Ramakrishnan S, Huss W, Foster B, Ohm J, Wang J, Azabdaftari G, et al. Transcriptional changes associated with in vivo growth of muscle-invasive bladder cancer cell lines in nude mice. Am J Clin Exp Urol 2018;6:138-48."},{"key":"54453","doi-asserted-by":"crossref","unstructured":"16. Ru R, Chen G, Liang X, Cao X, Yuan L, Meng M. Sea cucumber derived triterpenoid glycoside frondoside A: a potential anti-bladder cancer drug. Nutrients 2023;15:378.","DOI":"10.3390\/nu15020378"},{"key":"54454","doi-asserted-by":"crossref","unstructured":"17. Yang X, Song W, Lu Z, Chen Y, Wang Y, Huang T, et al. Lycopene mitigates T-2 toxin-induced hepatic ferroptosis by targeting the Nrf2\/mitophagy axis in mice. Npj Sci Food 2026;10:94.","DOI":"10.1038\/s41538-026-00736-4"},{"key":"54455","doi-asserted-by":"crossref","unstructured":"18. Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol 2020;38:1895-904.","DOI":"10.1007\/s00345-019-02984-4"},{"key":"54456","doi-asserted-by":"crossref","unstructured":"19. Jian N, Yu L, Ma L, Zheng B, Huang W. BCG therapy in bladder cancer and its tumor microenvironment interactions. Clin Microbiol Rev 2025;38:e0021224.","DOI":"10.1128\/cmr.00212-24"},{"key":"54457","doi-asserted-by":"crossref","unstructured":"20. Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci 2022;24:449.","DOI":"10.3390\/ijms24010449"},{"key":"54458","doi-asserted-by":"crossref","unstructured":"21. Liu X, Chen C, Han D, Zhou W, Cui Y, Tang X, et al. SLC7A11\/GPX4 inactivation-mediated ferroptosis contributes to the pathogenesis of triptolide-induced cardiotoxicity. Oxid Med Cell Longev 2022;2022:3192607.","DOI":"10.1155\/2022\/3192607"},{"key":"54459","doi-asserted-by":"crossref","unstructured":"22. Li W, Ou Y, Ye F, Cheng Z, Chen Z, Zhou Q, et al. cirSIRT5 induces ferroptosis in bladder cancer by forming a ternary complex with SYVN1\/PHGDH. Cell Death Discov 2024;10:391.","DOI":"10.1038\/s41420-024-02163-4"},{"key":"54460","doi-asserted-by":"crossref","unstructured":"23. Sun Y, Berleth N, Wu W, Schl\u00fctermann D, Deitersen J, Stuhldreier F, et al. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death Dis 2021;12:1028.","DOI":"10.1038\/s41419-021-04306-2"},{"key":"54461","doi-asserted-by":"crossref","unstructured":"24. Zhao Y, Ren P, Yang Z, Wang L, Hu C. Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis. Oncol Rep 2023;49:16.","DOI":"10.3892\/or.2022.8453"},{"key":"54462","doi-asserted-by":"crossref","unstructured":"25. Suzuki T, Takahashi J, Yamamoto M. Molecular basis of the KEAP1-NRF2 signaling pathway. Mol Cells 2023;46:133-41.","DOI":"10.14348\/molcells.2023.0028"},{"key":"54463","doi-asserted-by":"crossref","unstructured":"26. Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol 2020;40:e00020-99.","DOI":"10.1128\/MCB.00099-20"},{"key":"54464","unstructured":"27. Shao YQ, Sheng DY, Guan YJ, Mi EXT, Hu CY, Lu QF, et al. [Mechanism of periplogenin in promoting Nrf2 degradation and inducing ferroptosis to inhibit bladder cancer].[Article in Chinese with English Abstract]. Zhongguo Zhong Yao Za Zhi 2025;50:5790-9."},{"key":"54465","doi-asserted-by":"crossref","unstructured":"28. Zhang Y, Liang J. Research progress on the KMT2A-AFF3 fusion gene in childhood acute lymphoblastic leukemia: mechanisms, clinical implications, and therapeutic strategies. Curr Issues Mol Biol 2025;47:988.","DOI":"10.3390\/cimb47120988"},{"key":"54466","doi-asserted-by":"crossref","unstructured":"29. Mueller D, Garc\u00eda-Cu\u00e9llar MP, Bach C, Buhl S, Maethner E, Slany RK. Misguided transcriptional elongation causes mixed lineage leukemia. Plos Biol 2009;7:e1000249.","DOI":"10.1371\/journal.pbio.1000249"},{"key":"54467","doi-asserted-by":"crossref","unstructured":"30. Jadhav B, Garg P, van Vugt JJFA, Ibanez K, Gagliardi D, Lee W, et al. A phenome-wide association study of methylated GC-rich repeats identifies a GCC repeat expansion in AFF3 associated with intellectual disability. Nat Genet 2024;56:2322-32.","DOI":"10.1038\/s41588-024-01917-1"}],"container-title":["European Journal of Histochemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.ejh.it\/ejh\/article\/download\/4756\/3833","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejh.it\/ejh\/article\/download\/4756\/3833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:36:23Z","timestamp":1792668983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejh.it\/ejh\/article\/view\/4756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,10,7]]}},"URL":"https:\/\/doi.org\/10.4081\/ejh.2026.4756","relation":{},"ISSN":["2038-8306","1121-760X"],"issn-type":[{"value":"2038-8306","type":"electronic"},{"value":"1121-760X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}